Fundraising Fox
Metaphorebio
52 employees on LinkedIn · 2 known investors
Find your way into Metaphorebio
Sign up to find every way you can get introduced to Metaphorebio
- Your email: who you already know at Metaphorebio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Metaphorebio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Metaphore develops a platform that measures biological activity inside cells at scale to design antibody medicines with novel mechanisms of action. The company aims to create antibodies that activate pathways, modulate signaling, and engage multiple targets to treat complex diseases.
Investors · 2
Related companies · 2
Fore BiotherapeuticsFore Biotherapeutics is a clinical-stage oncology company developing targeted cancer therapies, including its lead plixorafenib program. It runs clinical trials such as the Forte Trial and offers expanded access programs for patients.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies working in the same space as Metaphorebio.
Frequently asked questions
- What does Metaphorebio do?
- Metaphore develops a platform that measures biological activity inside cells at scale to design antibody medicines with novel mechanisms of action. The company aims to create antibodies that activate pathways, modulate signaling, and engage multiple targets to treat complex diseases.
- Who are Metaphorebio's investors?
- Metaphorebio's investors include Flagship Pioneering, Global Brain.